Brain regions involved in fatigue sensation: Reduced acetylcarnitine uptake into the brain

NeuroImage

Volumn 17, Issue 3, 2002, Pages 1256-1265

  Kuratsune, Hirohiko ^a   Yamaguti, Kouzi ^a,b   Lindh, Gudrun ^c   Evengård, Birgitta ^c   Hagberg, Gisela ^d   Matsumura, Kiyoshi ^e   Iwase, Masao ^a   Onoe, Hirotaka ^f   Takahashi, Mamoru ^g   Machii, Takashi ^a   Kanakura, Yuzuru ^a   Kitani, Teruo ^a   Långström, Bengt ^d   Watanabe, Yasuyoshi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e KYOTO UNIVERSITY   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^g ASAHI CHEMICAL INDUSTRY CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; ACETYLCARNITINE; CARBON; GLUTAMIC ACID; LEVACECARNINE;

AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CEREBELLUM; CHRONIC FATIGUE SYNDROME; CINGULATE GYRUS; CONTROLLED STUDY; FATIGUE; MALE; METABOLITE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; TEMPORAL CORTEX;

EID: 0036429750     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1006/nimg.2002.1260     Document Type: Article

References (38)

1. Andersson, J. L. R., Onoe, H., Hetta, J., Lidstöm, K., Valind, S., Lilja, A., Sundin, A., Fasth, K. J., Westerberg, G., Broman, J. E., Watanabe, Y., and Langstrom, B. 1998. Brain networks affected by synchronized sleep visualized by positron emission tomography. J. Cereb. Blood Flow Metab. 18: 701-715.
2. 1H-NMR spectroscopy. Brain Res. 643: 92-99.
3. Bench, C. J., Friston, K. J., Brown, R. G., Scott, L. C., Frackowiak, R. S., and Dolan, R. J. 1992. The anatomy of melancholia - Focal abnormalities of cerebral blood flow in major depression. Psychol. Med. 22: 607-615.
4. Bench, C. J., Frackowiak, R. S., and Dolan, R. J. 1995. Changes in regional cerebral blood flow on recovery from depression. Psychol. Med. 25: 247-261.
5. Costa, D. C., Tannock, C., and Brostoff, J. 1995. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 88: 767-773.
6. Dell'Anna, E., Iuvone, L., Calzolari, S., and Geloso, M. C. 1997. Effect of acetyl-L-carnitine on hyperactivity and spatial memory deficits of rats exposed to neonatal anoxia. Neurosci. Lett. 223: 201-205.
7. Drevets, W. C., Price, J. L., Simpson, J. R., Jr., Todd, R. D., Reich, T., Vannier, M., and Raichle, M. E. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827.
8. Fariello, R. G., Ferraro, T. N., Golden, G. T., and DeMattei, M. 1988. Systemic acetyl-L-carnitine elevates nigral levels of glutathione and GABA. Life Sci. 43: 289-292.
9. Farrell, S., Vogel, J., and Bieber, L. L. 1986. Entry of acetyl-L-carnitine into biosynthetic pathways. Biochim. Biophys. Acta 876: 175-177.
10. Fischler, B., D'Haenen, H., Cluydts, R., Michiels, V., Demets, K., Bossuyt, A., Kaufman, L., and De Meirleir, K. 1996. Comparison of 99m Tc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: An exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology 34: 175-183.
11. Forloni, G., Angeretti, N., and Smiroldo, S. 1994. Neuroprotective activity of acetyl-L-carnitine: Studies in vitro. J. Neurosci. Res. 37: 92-96.
12. Friston, K. J., Worsley, K. J., Frackowiak, R. S., Mazziotta, J. C., and Evans, A. C. 1994. Assessing the significance of focal activations using their spatial extent. Hum. Brain Mapping 1: 210-220.
13. Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., and Komaroff, A. 1994. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 121: 953-959.
14. Galynker, II, Cai, J., Ongseng, F., Finestone, H., Dutta, E., and Serseni, D. 1998. Hypofrontality and negative symptoms in major depressive disorder. J. Nuclear Med. 39: 608-612.
15. Ghirardi, O., Milano, S., Ramacci, M. T., and Angelucci, L. 1988. Effect of acetyl-L-carnitine chronic treatment on discrimination models in aged rats. Physiol. Behav. 44: 769-773.
16. Greitz, T., Bohm, C., Holte, S., and Eriksson, L. 1991. A computerized brain atlas: Construction, anatomical content, and some applications. J. Comput. Assist. Tomogr. 15: 26-38.
17. 15O. I. Theory and error analysis. J. Nuclear Med. 24: 782-789.
18. Ichise, M., Salit, I. E., Abbey, S. E., Chung, D. G., Gray, B., Kirsh, J. C., and Freedman, M. 1992. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nuclear Med. Commun. 13: 767-772.
19. 11C]carnitine labelled in specific positions, applied in PET studies on rhesus monkey. Nuclear Med. Biol. 24: 471-478.
20. Kim, C. S., and Roe, C. R. 1992. Maternal and fetal tissue distribution of L-carnitine in pregnant mice: Low accumulation in the brain. Fundam. Appl. Toxicol. 19: 222-227.
21. Kuratsune, H., Yamaguti, K., Takahashi, M., Misaki, H., Tagawa, S., and Kitani, T. 1994. Acylcarnitine deficiency in chronic fatigue syndrome. Clin. Infect. Dis. 18: S62-67.
22. 11C]acetyl-L-carnitine into the brain: A PET study. Biochem. Biophys. Res. Commun. 231: 488-493.
23. Kuratsune, H., Yamaguti, K., Watanabe, Y., Takahashi, M., Nakamoto, I., Machii, T., Jacobsson, G., Onoe, H., Matsumura, K., Valind, S., Langstrom, B., and Kitani, T. 1997b. Acylcarnitine and chronic fatigue syndrome. In Carnitine Today (C. DeSimone and G. Famularp, Eds.), pp. 195-213. Landes Bioscience, Austin, TX.
24. Kuratsune, H., Yamaguti, K., Lindh, G., Evengard, B., Takahashi, M., Machii, T., Matsumura, K., Takaishi, J., Kawata, S., Langstrom, B., Kanakura, Y., Kitani, T., and Watanabe, Y. 1998. Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases. Int. J. Mol. Med. 2: 51-56.
25. Lolic, M. M., Fiskum, G., and Rosenthal, R. E. 1997. Neuroprotective effects of acetyl-L-carnitine after stroke in rats. Ann. Emerg. Med. 29: 758-765.
26. Mayberg, H. S., Brannan, S. K., Mahurin, R. K., Jerabek, P. A., Brickman, J. S., Tekell, J. L., Silva, J. A., McGinnis, S., Glass, T. G., Martin, C. C., and Fox, P. T. 1997. Cingulate function in depression: A potential predictor of treatment response. Neuroreport 8: 1057-1061.
27. 15O autoradiographic method and dynamic PET. J. Nuclear Med. 30: 1069-1078.
28. Pettegrew, J. W., Klunk, W. E., Panchalingam, K., Kanfer, J. N., and McClure, R. J. 1995. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol. Aging 16: 1-4.
29. Ricciolini, R., Scalibastri, M., Kelleher, J. K., Carminati, P., Calvani, M., and Arduini, A. 1998. Role of acetyl-L-carnitine in rat brain lipogenesis: Implications for polyunsaturated fatty acid biosynthesis. J. Neurochem. 71: 2510-2517.
30. Roberts, A., Weiskrantz, L., and Robbins, T. W. 1988. The Prefrontal Cortex: Executive and Cognitive Functions. Oxford Univ. Press, London.
31. 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48: 1566-1571.
32. Schlegel, S., Aldenhoff, J. B., Eissner, D., Lindner, P., and Nickel, O. 1989. Regional cerebral blood flow in depression: Associations with psychopathology. J. Affect. Disord. 17: 211-218.
33. Schwartz, R. B., Garada, B. M., Komaroff, A. L., Tice, H. M., Gleit, M., Jolesz, F. A., and Holman, B. L. 1994. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: Comparison of MR imaging and SPECT. Am. J. Roentgenol. 162: 935-941.
34. Shug, A. L., Schmidt, M. J., Golden, G. T., and Fariello, R. G. 1982. The distribution and role of carnitine in the mammalian brain. Life Sci. 31: 2869-2874.
35. Tirelli, U., Chierichetti, F., Tavio, M., Simonelli, C., Bianchin, G., Zanco, P., and Ferlin, G. 1998. Brain positron emission tomography (PET) in chronic fatigue syndrome: Preliminary data. Am. J. Med. 105: 54S-58S.
36. Worsley, K. J., Poline, J. B., Vandal, A. C., and Friston, K. J. 1995. Tests for distributed, nonfocal brain activations. Neuroimage 2: 183-194.
37. Wu, X., Huang, W., Prasad, P. D., Seth, P., Rajan, D. P., Leibach, F. H., Chen, J., Conway, S. J., and Ganapathy, V. 1999. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J. Pharmacol. Exp. Ther. 290: 1482-1492.
38. Yamaguti, K., Kuratsune, H., Watanabe, Y., Takahashi, M., Nakamoto, I., Machii, T., Jacobsson, G., Onoe, H., Matsumura, K., Valind, S., Langstrom, B., and Kitani, T. 1996. Acylcarnitine metabolism during fasting and after refeeding. Biochem. Biophys. Res. Commun. 225: 740-746.